Learn More
6577 Background: First-line treatment with chemotherapy/rituximab combinations improves complete remission (CR) rates and lengthens remission duration in patients with follicular NHL. We previously(More)
7127 Background: Abraxane (A) is a cremophor free, albumin-bound nanoparticle of paclitaxel (P) approved for the treatment of metastatic breast cancer. Belani et al. (JCO 21: 2933-2939, 2003)(More)